Category: Pharmaceuticals
Pharmaceuticals market research reports by Euromonitor International
-
Rx/Reimbursement Adult Incontinence in Sweden
RX/reimbursement adult incontinence saw steady growth in value and volume terms in 2024. Value growth was primarily driven by two key factors: Sweden’s ageing population and the rising prevalence of obesity and type 2 diabetes. A strong correlation exists between age, underlying health conditions an ... Read More
-
Rx/Reimbursement Adult Incontinence in Poland
In 2024, Rx/reimbursement adult incontinence in Poland continued to post healthy retail volume and current value growth, albeit slower than in 2023 and other years of the review period. As in the retail sphere, demand increased alongside a growing number of consumers in older cohorts, who are more l ... Read More
-
Rx/Reimbursement Adult Incontinence in Slovakia
The landscape of Rx/reimbursement adult incontinence in Slovakia underwent notable changes in 2024 due to regulatory adjustments. From April 2024, new legislation was introduced to refine the prescription process, mandating that doctors indicate the specific level of incontinence on a designated vou ... Read More
-
Rx/Reimbursement Adult Incontinence in Hungary
Current value sales growth of Rx/reimbursement adult incontinence products in Hungary in 2024 was significantly higher compared to retail adult incontinence products. as local consumers could be reimbursed by up to 80% by insurance companies. Doctors determine the appropriate payment group for each ... Read More
-
Rx/Reimbursement Adult Incontinence in Norway
Value sales of RX/reimbursement adult incontinence increased in 2024, driven by an ageing population and a rising obesity rate. The natural expansion of the potential user base contributed to steady demand, while growing health consciousness and hygiene awareness further encouraged individuals to se ... Read More
-
Rx/Reimbursement Adult Incontinence in Denmark
Value sales of RX/reimbursement adult incontinence grew in 2024 in Denmark, supported by the ageing population. It is estimated that around 80% of reimbursement recipients are aged 65 and older, a group that is expanding as life expectancy increases. The ageing population, coupled with rising obesit ... Read More
-
Rx/Reimbursement Adult Incontinence in the Czech Republic
Rx/reimbursement adult incontinence saw volume and value growth in the Czech Republic in 2024. The growth of the category is being fuelled not just by the ageing population but also by more information about Rx rights and reimbursements via magazines and pharmacies. Since 1 January 2024, the VAT rat ... Read More
-
Rx/Reimbursement Adult Incontinence in the Netherlands
Value sales of RX/reimbursement adult incontinence increased modestly in 2024, but negative volume growth continued to exert downward pressure on overall performance. Many consumers opted to purchase incontinence products through retail channels or e-commerce platforms rather than rely on reimbursed ... Read More
-
Menstrual Care in Vietnam
Value sales of menstrual care products in Vietnam rose strongly 2024, driven by a slight increase in the female population (50.1% of the total), higher hygiene standards and increased awareness of proper menstrual care. Educational efforts in high schools addressing early sexual precocity have also ... Read More
-
Cannabis in Brazil
The year 2024 was one of the most dynamic for the cannabis industry in Brazil. In the medical segment, which is amongst the top 10 global markets in USD value, cannabis-based medications started to be distributed through the public health system of Brazil’s most populous state. Moreover, ANVISA (Bra ... Read More
-
Rx/Reimbursement Adult Incontinence in Colombia
Despite significant challenges within Colombia’s healthcare system – including government interventions affecting major EPS providers such as Sanitas, Nueva EPS, and Famisanar, as well as the financial struggles prompting Sura and Compensar to request withdrawal from the system – Rx/reimbursement in ... Read More
-
Cannabis in Poland
Poland is an established economic powerhouse in Eastern Europe. The country’s impressive growth rate over the past two decades has turned it into one of the most important economies in the whole of Europe, especially evident in the turbulent geopolitical climate. While currently the cannabis market ... Read More
-
Rx/Reimbursement Adult Incontinence in Italy
Rx/reimbursement adult incontinence continued to decline in both volume and current value terms in Italy in 2024 as the National Sanitary System lowered budgets to tackle the country’s massive debt. The basic comfort of these products, coupled with growing consumer acceptance of partial out-of-pocke ... Read More
-
Rx/Reimbursement Adult Incontinence in the US
Rx/reimbursement adult incontinence in the US maintained stable volume and current value growth in 2024. Nevertheless, post-pandemic, Medicaid disenrollment was underway, after three years of continuous enrolment. During the pandemic, states operated under a policy of continuous enrolment, which off ... Read More
-
Rx/Reimbursement Adult Incontinence in France
Value sales of Rx/reimbursement adult incontinence increased in 2024 in France, as did volume sales. In France, these products sustained a positive growth trend over the year, driven by their essential nature, which makes them difficult to substitute. Demand stems largely from an ageing population a ... Read More
-
Rx/Reimbursement Adult Incontinence in Germany
Value sales of rx/reimbursement adult incontinence in Germany continued to rise in 2024, mainly driven by ongoing high production costs and persistent inflation. On the other hand, retail volume sales continued to slowly decline. The demand for rx/reimbursement adult incontinence in Germany is prima ... Read More
-
New Consumer Journey in Health Products in Asia
Health-conscious consumers in Asia utilise diverse information sources to make their health purchases, especially online. These purchasing journeys generally fall into two categories: Symptom-driven decisions, which are more immediate and spontaneous, and long-term health management, which involves ... Read More
-
Pharmaceuticals in Mexico: ISIC 2423
PPI Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals: ISIC 2423 market at a national level. It provides the latest retail sales data, allowing you to identif ... Read More
-
Voice of the Consumer: Consumer Health 2024
This report highlights the results of Euromonitor International’s 2024 Voice of the Consumer: Health & Nutrition Survey, uncovering key trends in relation to the consumer health industry. Consumer trends explored include the battle between branded and generic OTCs, the rise of holistic health, and t ... Read More
-
Cannabis in South Africa
During 2024, the South African legal cannabis market continued to develop, following enactment of the Cannabis for Private Purposes Act, which codified the 2018 landmark judgement into law, by formally legalising personal cultivation and use of cannabis in private spaces. In turn, the change in the ... Read More
-
Cannabis in the US
The cannabis legalisation landscape is rapidly changing, with more states legalising it for medical and recreational use, driving market growth and consumer access. Significant federal developments may include a potential rescheduling of cannabis from Schedule I to Schedule III, which could attract ... Read More
-
Cannabis in Italy
Cannabis in Italy The year 2023 was characterised by a decline in medical cannabis consumption in Italy. This dynamic was due to several factors. The main reason lay in the fact that during 2023 some Italian doctors, who were major prescribers of medical cannabis, retired and there was no generation ... Read More
-
Cannabis in Thailand
Cannabis in Thailand The cannabis market has continued to experience significant turmoil largely due to inconsistent regulations from the Thai government that have dampened consumer demand and eroded producer confidence. While demand appeared to be in decline, a substantial number of cannabis shops ... Read More
-
Cannabis in Israel
Cannabis in Israel The first six months of 2024 were characterised by fluctuating inflation, with the rate rising again in July 2024 to 3.2%. At the end of Q1 2024, there was reported economic growth of just over 14%. However, in Q2 2024, economic growth had fallen to just 1.2% showing that the econ ... Read More
-
Analgesics in India
Analgesics in India In 2024, analgesics in India is expected to experience high single-digit retail current value growth, driven by the increasing prevalence of lifestyle-related ailments. With more individuals working extended hours, often on digital devices, issues such as neck, back, and joint pa ... Read More
Research Assistance
